Development standard controls for multiplex qPCR technique to quantify Bacteroides fragilis, Fusobacterium nucleatum, Akkermansia muciniphila and Escherichia coli in colorectal cancer patients in tumors of colorectal cancer patients

Sơn Giang Vũ1, , Nguyễn Thị Thân1, Nguyễn Lĩnh Toàn2, Hồ Văn Sơn1
1 Bệnh viện Quân y 175
2 Học viện Quân y

Main Article Content

Abstract

Disorders of gut microbiota may alter physiological processes resulting in various diseases. The presence of toxigenic Bacteroides fragilis (ETBF), Fusobacterium nucleatum (Fn), Akkermansia muciniphila (Am) and Escherichia coli (E.coli), have been implicated as agents associated with onset and progression. of colorectal cancer through the secretion of toxins or oncogen activators.


As such, our study aimed to develop a standard calibrator; develop a simple, rapid technique to simultaneously detect ETBF, Fn, Am, E.coli in tumors of CRC patients using multiplex qPCR. Specific primers and probes were designed based on the highly conserved regions  of  ETBF, Fn, Am, E.coli, built a standard calibrator and optimized multiplex qPCR conditions. As a result, we have created four recombinant plasmids.The sensitivity of the technique reaches 10 copies, with correlation coefficient R2 >0.99; E > 93% and can be used as a standard control for analyzing the specimens from patients. At the same time, detected positivity for Fn, ETBF, and NTBF in 65%, 66%, 62%, and 36%. of the samples respectively (n = 100). These preliminary findings suggest that disruptions in the gut microbiota have the potential to serve as a biomarker for the early detection of CRC.

Article Details

References

1. Morgan E, Arnold M, Gini A, et al. Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN. Gut. 2022; 72(2):338-344. DOI:10.1136/gutjnl-2022-327736
2. Pandey H, Tang DWT, Wong SH, Lal D. Gut Microbiota in colorectal cancer: Biological role and therapeutic opportunities. Cancers (Basel). 2023; 15(3). DOI:10.3390/CANCERS15030866
3. Wang Q, Ye J, Fang D, et al. Multi-omic profiling reveals associations between the gut mucosal microbiome, the metabolome, and host DNA methylation associated gene expression in patients with colorectal cancer. BMC Microbiol. 2020; 20(1). DOI:10.1186/S12866-020-01762-2
4. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016; 14(8). DOI:10.1371/ JOURNAL.PBIO.1002533
5. Zhou Y, He H, Xu H, et al. Oncotarget 80794 www.impactjournals. com/oncotarget Association of oncogenic bacteria with colorectal cancer in South China. Oncotarget. 2016; 7(49):80794-80802. www.impactjournals.com/oncotarget/
6. Osman MA, Neoh H min, Ab Mutalib NS, et al. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer. Sci Rep. 2021; 11(1):1-12. DOI:10.1038/s41598-021-82465-0
7. Shariati A, Razavi S, Ghaznavi-Rad E, et al. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: A preliminary study. Infect Agent Cancer. 2021; 16(1):1-10. DOI:10.1186/s13027-021-00381-4
8. Tran HNH, Thu TNH, Nguyen PH, et al. Tumour microbiomes and Fusobacterium genomics in Vietnamese colorectal cancer patients. npj Biofilms Microbiomes 2022 81. 2022; 8(1):1-13. DOI:10.1038/s41522-022-00351-7
9. Tran CT Du, Nguyen MVT, Tran MT, et al. Findings from the first colorectal cancer screening among 103 542 individuals in Vietnam with systematic review of colorectal cancer screening programs in Asia-Pacific region. Jpn J Clin Oncol. 2022; 52(7):699-707. DOI:10.1093/JJCO/ HYAC043
10. Hou Y, Zhang H, Miranda L, Lin S. Serious overestimation in quantitative pcr by circular (supercoiled) plasmid standard: Microalgal pcna as the Model Gene. PLoS One. 2010; 5(3):e9545.DOI:10.1371/JOURNAL.PONE.0009545